{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:01:01Z","timestamp":1792735261832,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10067-020-05479-5","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T06:02:25Z","timestamp":1606197745000},"page":"2277-2284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc\u00a0cohorts"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2919-1966","authenticated-orcid":false,"given":"Yossra","family":"Suliman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Kafaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny J.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Alemam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Bagnato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Abignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram Raj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isela","family":"Valera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rezaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Galdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E","family":"Furst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"5479_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5301\/jsrd.5000249","volume":"2","author":"J Varga","year":"2017","unstructured":"Varga J, Trojanowska M, Kuwana M (2017) Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord. 2:137\u2013152. https:\/\/doi.org\/10.5301\/jsrd.5000249","journal-title":"J Scleroderma Relat Disord."},{"issue":"3","key":"5479_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5301\/jsrd.5000214","volume":"1","author":"AB Shreiner","year":"2016","unstructured":"Shreiner AB, Murray C, Denton C, Khanna D (2016) Gastrointestinal manifestations of systemic sclerosis J scleroderma relat disord 1(3):247\u2013256. https:\/\/doi.org\/10.5301\/jsrd.5000214","journal-title":"Gastrointestinal manifestations of systemic sclerosis J scleroderma relat disord"},{"key":"5479_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5301\/jsrd.5000199","volume":"1","author":"Y Suliman","year":"2016","unstructured":"Suliman Y, Srinivasan S, Maish MS, Federer LM, Furst DE (2016) Esophageal surgeries in systemic sclerosis (SSc) - a systematic review of the literature. J Scleroderma Relat Disord 1:10\u201315. https:\/\/doi.org\/10.5301\/jsrd.5000199","journal-title":"J Scleroderma Relat Disord"},{"key":"5479_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5301\/jsrd.5000233","volume":"2","author":"G Coiffier","year":"2017","unstructured":"Coiffier G, Cazalets C, J\u00e9go P et al (2017) Association between clinical manifestations of systemic sclerosis and esophageal dysmotility assessed by high-resolution manometry. J Scleroderma Relat Disord. 2:50\u201356. https:\/\/doi.org\/10.5301\/jsrd.5000233","journal-title":"J Scleroderma Relat Disord."},{"key":"5479_CR5","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/art.1780370902","volume":"37","author":"RW Sjogren","year":"1994","unstructured":"Sjogren RW (1994) Gastrointestinal motility disorders in scleroderma. Arthritis Rheum. 37:1265\u20131282. https:\/\/doi.org\/10.1002\/art.1780370902","journal-title":"Arthritis Rheum."},{"key":"5479_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.semarthrit.2006.08.002","volume":"36","author":"SK Ntoumazios","year":"2006","unstructured":"Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA (2006) Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum. 36:173\u2013181. https:\/\/doi.org\/10.1016\/j.semarthrit.2006.08.002","journal-title":"Semin Arthritis Rheum."},{"key":"5479_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/0016-5085(89)90770-1","volume":"96","author":"MP Greydanus","year":"1989","unstructured":"Greydanus MP, Camilleri M (1989) Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology. 96:110\u2013115. https:\/\/doi.org\/10.1016\/0016-5085(89)90770-1","journal-title":"Gastroenterology."},{"key":"5479_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1172\/JCI117395","volume":"94","author":"S Howe","year":"1994","unstructured":"Howe S, Eaker EY, Sallustio JE, Peebles C, Tan EM, Williams RC Jr (1994) Antimyenteric neuronal antibodies in scleroderma. J Clin Invest. 94:761\u2013770. https:\/\/doi.org\/10.1172\/JCI117395","journal-title":"J Clin Invest."},{"key":"5479_CR9","doi-asserted-by":"publisher","first-page":"G1206","DOI":"10.1152\/ajpgi.00286.2009","volume":"297","author":"F Del Galdo","year":"2009","unstructured":"Del Galdo F, Rattan S, Singh J et al (2009) Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells. Am J Physiol Liver Physiol. 297:G1206\u2013G1213. https:\/\/doi.org\/10.1152\/ajpgi.00286.2009","journal-title":"Am J Physiol Liver Physiol."},{"key":"5479_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1703327","volume":"378","author":"KM Sullivan","year":"2018","unstructured":"Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney P, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE, SCOT Study Investigators (2018) Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med. 378:35\u201347. https:\/\/doi.org\/10.1056\/NEJMoa1703327","journal-title":"N Engl J Med."},{"key":"5479_CR11","doi-asserted-by":"publisher","unstructured":"Choung RS, Saito YA (2014) Epidemiology of Irritable Bowel Syndrome. In GI Epidemiology: Diseases and Clinical Methodology: Second Edition,\u00a0Wiley Blackwell (pp. 222\u2013234). https:\/\/doi.org\/10.1002\/9781118727072.ch20","DOI":"10.1002\/9781118727072.ch20"},{"key":"5479_CR12","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1053\/j.gastro.2016.12.039","volume":"152","author":"F Klem","year":"2017","unstructured":"Klem F, Wadhwa A, Prokop LJ, Sundt WJ, Farrugia G, Camilleri M, Singh S, Grover M (2017) Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 152:1042\u20131054.e1. https:\/\/doi.org\/10.1053\/j.gastro.2016.12.039","journal-title":"Gastroenterology."},{"key":"5479_CR13","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s10620-014-3435-5","volume":"60","author":"M Pimentel","year":"2015","unstructured":"Pimentel M, Morales W, Pokkunuri V, Brikos C, Kim SM, Kim SE, Triantafyllou K, Weitsman S, Marsh Z, Marsh E, Chua KS, Srinivasan S, Barlow GM, Chang C (2015) Autoimmunity links vinculin to the pathophysiology of chronic functional bowel changes following campylobacter jejuni infection in a rat model. Dig Dis Sci. 60:1195\u20131205. https:\/\/doi.org\/10.1007\/s10620-014-3435-5","journal-title":"Dig Dis Sci."},{"key":"5479_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/excr.1996.0131","volume":"224","author":"CF Deroanne","year":"1996","unstructured":"Deroanne CF, Colige AC, Nusgens BV, Lapiere CM (1996) Modulation of expression and assembly of vinculin during in vitro fibrillar collagen-induced angiogenesis and its reversal. Exp Cell Res. 224:215\u2013223. https:\/\/doi.org\/10.1006\/excr.1996.0131","journal-title":"Exp Cell Res."},{"key":"5479_CR15","doi-asserted-by":"publisher","first-page":"e11530","DOI":"10.1371\/journal.pone.0011530","volume":"5","author":"W Xu","year":"1998","unstructured":"Xu W, Baribault H, Adamson ED (1998) Vinculin knockout results in heart and brain defects during embryonic development. Development. 5:e11530. https:\/\/doi.org\/10.1371\/journal.pone.0011530","journal-title":"Development."},{"key":"5479_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1006\/bbrc.2001.6243","volume":"290","author":"WH Goldmann","year":"2002","unstructured":"Goldmann WH, Ingber DE (2002) Intact vinculin protein is required for control of cell shape, cell mechanics, and rac-dependent lamellipodia formation. Biochem Biophys Res Commun. 290:749\u2013755. https:\/\/doi.org\/10.1006\/bbrc.2001.6243","journal-title":"Biochem Biophys Res Commun."},{"key":"5479_CR17","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/ar4270","volume":"15","author":"M Villano","year":"2013","unstructured":"Villano M, Borghini A, Manetti M, Gabbrielli E, Rossi A, Sestini P, Milia A, Nacci F, Guiducci S, Matucci-Cerinic M, Ibba-Manneschi L, Weber E (2013) Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide. Arthritis Res Ther. 15:R90. https:\/\/doi.org\/10.1186\/ar4270","journal-title":"Arthritis Res Ther."},{"key":"5479_CR18","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1183\/09031936.00181410","volume":"39","author":"H Dib","year":"2012","unstructured":"Dib H, Tamby MC, Bussone G, Regent A, Berezn\u00e9 A, Lafine C, Broussard C, Simonneau G, Guillevin L, Witko-Sarsat V, Humbert M, Mouthon L (2012) Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma. Eur Respir J. 39:1405\u20131414. https:\/\/doi.org\/10.1183\/09031936.00181410","journal-title":"Eur Respir J."},{"issue":"11","key":"5479_CR19","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 65(11):2737\u201347","journal-title":"Arthritis Rheum."},{"issue":"2","key":"5479_CR20","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u20135","journal-title":"J Rheumatol"},{"key":"5479_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5301\/jsrd.5000231","volume":"2","author":"D Khanna","year":"2017","unstructured":"Khanna D, Furst DE, Clements PJ, Allanore Y, Baron M, Czirjak L, Distler O, Foeldvari I, Kuwana M, Matucci-Cerinic M, Mayes M, Medsger T, Merkel PA, Pope JE, Seibold JR, Steen V, Stevens W, Denton CP (2017) Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis. J scleroderma Relat Disord. 2:11\u201318. https:\/\/doi.org\/10.5301\/jsrd.5000231","journal-title":"J scleroderma Relat Disord."},{"key":"5479_CR22","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1002\/acr.20598","volume":"63","author":"J Pope","year":"2011","unstructured":"Pope J (2011) Measures of systemic sclerosis (scleroderma): health assessment questionnaire (HAQ) and scleroderma HAQ (SHAQ), physician- and patient-rated global assessments, symptom burden index (SBI), University of California, Los Angeles, scleroderma clinical trials. Arthritis Care Res. 63:S98\u2013S111. https:\/\/doi.org\/10.1002\/acr.20598","journal-title":"Arthritis Care Res."},{"issue":"5","key":"5479_CR23","doi-asserted-by":"publisher","first-page":"e0126438","DOI":"10.1371\/journal.pone.0126438","volume":"10","author":"M Pimentel","year":"2015","unstructured":"Pimentel M, Morales W, Rezaie A, Marsh E, Lembo A et al (2015) Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human Subjects. PLOS ONE 10(5):e0126438. https:\/\/doi.org\/10.1371\/journal.pone.0126438","journal-title":"PLOS ONE"},{"key":"5479_CR24","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1007\/s10620-017-4585-z","volume":"62","author":"A Rezaie","year":"2017","unstructured":"Rezaie A, Park SC, Morales W, Marsh E, Lembo A, Kim JH, Weitsman S, Chua KS, Barlow GM, Pimentel M (2017) Assessment of anti-vinculin and anti-cytolethal distending toxin B antibodies in subtypes of irritable bowel syndrome. Dig Dis Sci. 62:1480\u20131485. https:\/\/doi.org\/10.1007\/s10620-017-4585-z","journal-title":"Dig Dis Sci."},{"key":"5479_CR25","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/apt.13963","volume":"45","author":"S Kumar","year":"2017","unstructured":"Kumar S, Singh J, Rattan S, DiMarino AJ, Cohen S, Jimenez SA (2017) Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis. Aliment. Pharmacol. Ther. 45:883\u2013898","journal-title":"Aliment. Pharmacol. Ther."},{"key":"5479_CR26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/157339710904140417123932","volume":"9","author":"YA Suliman","year":"2013","unstructured":"Suliman YA, Distler O (2013) Novel aspects in the pathophysiology of peripheral vasculopathy in systemic sclerosis. Curr Rheumatol Rev 9:237\u2013244. https:\/\/doi.org\/10.2174\/157339710904140417123932","journal-title":"Curr Rheumatol Rev"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05479-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T22:16:40Z","timestamp":1621030600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05479-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5479"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05479-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"12 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Yossra Suliman, Suzanne Kafaja, Sunny J OH, G. Bagnato, G. Abignano, X. Liu, M. Alemam, I. Valera, RR. Singh, G. Barlow, F. Del Galdo, and D.E. Furst have no disclosures. Dr. Pimentel is a board member of Gemelli Biotech and has equity in this company (> $10,000). Ali Rezaie has received speaker\/consultant fees and research funding from Valeant Pharmaceuticals and has equity in Gemelli Biotech (all > $10,000). Walter Morales is a consultant for Gemelli Biotech (< $10,000).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}